Literature DB >> 16802769

The role of chemokines in exercise-induced bronchoconstriction in asthma.

Fulya Tahan1, Cagatay Karaaslan, Ayse Aslan, Nural Kiper, Omer Kalayci.   

Abstract

BACKGROUND: The pathogenesis of exercise-induced bronchoconstriction in asthma is incompletely understood, and the role of chemokines has not been investigated.
OBJECTIVE: To investigate the involvement of the CC chemokines eotaxin, regulated upon activation normal T-cell expressed and secreted (RANTES), thymus and activation-regulated chemokine (TARC), and the CXC chemokine interferon-gamma-inducible protein 10 (IP-10) in exercise-induced bronchoconstriction.
METHODS: Four groups were enrolled: asthmatic children with positive (n = 15) and negative (n = 15) responses to exercise, children with cystic fibrosis (n = 14), and healthy children (n = 11). Levels of eotaxin, RANTES, TARC, and IP-10 were determined in plasma before, immediately after, and 6 and 24 hours after exercise challenge using enzyme-linked immunosorbent assay. Transcriptional activity was measured using reverse transcriptase-polymerase chain reaction.
RESULTS: Exercise did not induce any significant changes in systemic chemokine levels. A significant difference was observed only in the preexercise IP-10 levels among groups (P = .045). There was a significant difference in peripheral blood eosinophil counts among groups (P = .003). In asthmatic children with a positive response to exercise, there was an inverse correlation between eosinophil counts and eotaxin levels (r = -0.616; P = .01) and between forced expiratory volume in 1 second and TARC levels (r = -0.865; P = .001). Reverse transcriptase-polymerase chain reaction studies did not show any difference in the transcription of the chemokines.
CONCLUSIONS: Exercise does not cause any changes in the systemic expression of eosinophilic chemokines. Peripheral blood eosinophils may be a determinant of the exercise response, and eotaxin and TARC may be associated with eosinophil counts and forced expiratory volume in 1 second in children with a bronchoconstrictor response to exercise.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16802769     DOI: 10.1016/S1081-1206(10)61344-0

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

1.  A single session of intense exercise improves the inflammatory response in healthy sedentary women.

Authors:  Juan José García; Elena Bote; Maria D Hinchado; Eduardo Ortega
Journal:  J Physiol Biochem       Date:  2010-10-09       Impact factor: 4.158

2.  Type 2 Inflammatory Biomarker Response After Exercise Challenge Testing.

Authors:  Ellen Tufvesson; Henning Stenberg; Jaro Ankerst; Leif Bjermer
Journal:  J Asthma Allergy       Date:  2020-08-24

Review 3.  Etiology of exercise-induced asthma: physical stress-induced transcription.

Authors:  Thomas Hilberg
Journal:  Curr Allergy Asthma Rep       Date:  2007-04       Impact factor: 4.806

4.  Exercise-induced asthma: critical analysis of the protective role of montelukast.

Authors:  Terrence W Carver
Journal:  J Asthma Allergy       Date:  2009-10-22

5.  The association of forced expiratory volume in one second and forced expiratory flow at 50% of the vital capacity, peak expiratory flow parameters, and blood eosinophil counts in exercise-induced bronchospasm in children with mild asthma.

Authors:  H Haluk Akar; Fulya Tahan; Hatice Eke Gungor
Journal:  Asia Pac Allergy       Date:  2015-04-29

6.  Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects.

Authors:  Francesca Accattato; Marta Greco; Salvatore A Pullano; Ilaria Carè; Antonino S Fiorillo; Arturo Pujia; Tiziana Montalcini; Daniela P Foti; Antonio Brunetti; Elio Gulletta
Journal:  PLoS One       Date:  2017-06-05       Impact factor: 3.240

7.  Challenges in identifying asthma subgroups using unsupervised statistical learning techniques.

Authors:  Mattia C F Prosperi; Umit M Sahiner; Danielle Belgrave; Cansin Sackesen; Iain E Buchan; Angela Simpson; Tolga S Yavuz; Omer Kalayci; Adnan Custovic
Journal:  Am J Respir Crit Care Med       Date:  2013-12-01       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.